GlassScriptPhysician profile
William Haberlin
NPI 1912106279
$11,316.42
in general payments reported to CMS, 2019-2025
37 companies · $1,409 in 2025
The $1,409 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,545 · 2020: $430 · 2021: $609 · 2022: $3,567 · 2023: $919 · 2024: $2,838 · 2025: $1,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,389 · Travel and Lodging: $1,769 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,389.07 |
| Travel and Lodging | $1,769.03 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,628.95 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,991.56 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Enterra Medical, INC. | $1,264.04 | 2024-2025 | |
| Ethicon US, LLC | $828.08 | 2021-2025 | Harmonic, Evarrest, Ethicon |
| Medtronic, INC. | $373.10 | 2021-2025 | Signia, Endurant Iis, Eea |
| Smith+Nephew, INC. | $349.91 | 2019-2025 | Grafix Pl, Stravix, Stravix Pl |
| Janssen Pharmaceuticals, INC | $216.49 | 2020-2024 | Xarelto |
| Novo Nordisk INC | $186.14 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $164.93 | 2020-2024 | Gattex |
| Davol INC. | $137.00 | 2019-2025 | Phasix Mesh |
| Boston Scientific Corporation | $129.43 | 2020-2025 | Spyscope Ds, Spyglass Discover |
| Teleflex LLC | $119.84 | 2022-2025 | Titan Sgs Bailout Chuck |
| Tela Bio, INC. | $87.02 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $64.85 | 2019-2023 | Spy-Phi System |
| Organogenesis INC. | $56.40 | 2025 | Affinity, Cygnus Dual, Puraply Wound Matrix |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $54.48 | 2020 | |
| Abbvie INC. | $50.60 | 2021 | |
| Supreme Orthopedic Systems, LLC | $47.79 | 2024 | |
| Tactile Systems Technology INC | $47.63 | 2024 | Flexitouch Plus, Entre Plus |
| Abbott Laboratories | $46.79 | 2020 | |
| Philips North America LLC | $44.13 | 2021-2023 | |
| Endo Pharmaceuticals INC. | $43.63 | 2020-2022 | |
| Medela LLC | $42.88 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $41.70 | 2022 | |
| Surmodics, INC. | $36.73 | 2022-2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Pounce Thrombectomy |
| Bolton Medical INC | $34.77 | 2021-2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $30.26 | 2025 | |
| Innocoll Pharmaceuticals Limited | $25.93 | 2022 | |
| Inari Medical, INC. | $25.57 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Integra Lifesciences Corporation | $24.42 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Shire North American Group INC | $21.11 | 2019 | |
| Elutia, INC. | $19.60 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.56 | 2024 | |
| Kci USA, INC. | $18.00 | 2019 | |
| Heron Therapeutics, INC. | $17.87 | 2021 | |
| Covidien LP | $13.73 | 2019 | |
| Thd America, INC. | $11.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Haberlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.